US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 20.460
  • +0.420+2.10%
Close Nov 25 16:00 ET
73.41MMarket Cap-2822P/E (TTM)

Aligos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
6.38%74.92M
4.07%94.54M
8.91%112.74M
7.85%135.7M
7.85%135.7M
-50.51%70.43M
-42.99%90.84M
-43.50%103.52M
-34.03%125.83M
-34.03%125.83M
-Cash and cash equivalents
-49.83%35.33M
-50.37%45.08M
-69.30%24.15M
66.82%135.7M
66.82%135.7M
-18.52%70.43M
27.62%90.83M
-24.76%78.67M
-56.46%81.35M
-56.46%81.35M
-Short-term investments
--39.59M
494,480.00%49.46M
256.56%88.59M
--0
--0
--0
-99.99%10K
-68.41%24.85M
1,035.27%44.48M
1,035.27%44.48M
Restricted cash
48.65%110K
66.67%70K
-45.59%216K
-39.13%70K
-39.13%70K
-7.50%74K
100.00%42K
-74.53%397K
-29.88%115K
-29.88%115K
Other current assets
15.70%4.79M
47.61%4.96M
-7.38%5.11M
-30.16%5.31M
-30.16%5.31M
-46.30%4.14M
-59.58%3.36M
-46.42%5.52M
-43.79%7.6M
-43.79%7.6M
Total current assets
6.94%79.82M
5.65%99.57M
7.89%118.06M
5.65%141.08M
5.65%141.08M
-50.27%74.64M
-43.80%94.24M
-43.90%109.43M
-34.67%133.55M
-34.67%133.55M
Non current assets
Net PPE
-24.72%7.97M
-23.56%8.61M
-21.10%9.21M
-21.54%9.82M
-21.54%9.82M
-20.54%10.59M
-20.81%11.26M
-20.98%11.68M
-16.40%12.51M
-16.40%12.51M
-Gross PPE
-8.48%19.51M
-8.24%19.9M
-4.96%20.62M
-6.83%20.57M
-6.83%20.57M
-4.70%21.32M
-4.58%21.69M
-4.47%21.7M
-0.67%22.08M
-0.67%22.08M
-Accumulated depreciation
-7.54%-11.54M
-8.31%-11.29M
-13.84%-11.41M
-12.41%-10.76M
-12.41%-10.76M
-18.64%-10.73M
-22.56%-10.43M
-26.27%-10.02M
-31.75%-9.57M
-31.75%-9.57M
Other non current assets
1.93%635K
1.12%631K
-1.11%625K
-1.42%625K
-1.42%625K
-4.59%623K
1.30%624K
2.60%632K
-26.79%634K
-26.79%634K
Total non current assets
-23.24%8.6M
-22.26%9.24M
-20.07%9.84M
-20.57%10.44M
-20.57%10.44M
-19.80%11.21M
-19.89%11.89M
-20.04%12.31M
-57.51%13.15M
-57.51%13.15M
Total assets
3.00%88.43M
2.53%108.81M
5.06%127.9M
3.30%151.53M
3.30%151.53M
-47.67%85.85M
-41.85%106.13M
-42.16%121.74M
-37.68%146.69M
-37.68%146.69M
Liabilities
Current liabilities
Payables
-1.68%9.75M
1.16%12.58M
-28.10%8.99M
-25.34%9.66M
-25.34%9.66M
-5.94%9.91M
9.07%12.43M
-31.01%12.5M
-37.09%12.94M
-37.09%12.94M
-accounts payable
-6.83%2.74M
110.40%6.82M
0.71%2.84M
-46.87%2.52M
-46.87%2.52M
0.34%2.94M
17.34%3.24M
-24.85%2.82M
57.11%4.74M
57.11%4.74M
-Other payable
0.49%7.01M
-37.36%5.76M
-36.49%6.15M
-12.91%7.14M
-12.91%7.14M
-8.36%6.97M
6.43%9.19M
-32.63%9.68M
-53.27%8.2M
-53.27%8.2M
Current accrued expenses
118.19%2.75M
87.86%2.71M
25.03%2.84M
105.36%3.03M
105.36%3.03M
38.05%1.26M
68.34%1.44M
98.69%2.27M
19.27%1.47M
19.27%1.47M
Current debt and capital lease obligation
4.45%3.4M
3.65%3.36M
3.97%3.27M
3.05%3.24M
3.05%3.24M
1.50%3.26M
10.33%3.24M
-4.43%3.15M
8.12%3.14M
8.12%3.14M
-Current capital lease obligation
4.45%3.4M
3.65%3.36M
3.97%3.27M
3.05%3.24M
3.05%3.24M
1.50%3.26M
10.33%3.24M
-4.43%3.15M
8.12%3.14M
8.12%3.14M
Current deferred liabilities
-83.42%655K
-80.93%1.33M
-89.74%721K
-85.80%1.31M
-85.80%1.31M
-63.17%3.95M
-47.06%6.95M
-53.36%7.03M
20.53%9.21M
20.53%9.21M
Other current liabilities
----
----
----
----
----
-91.95%7K
-80.92%25K
-76.04%46K
-76.09%66K
-76.09%66K
Current liabilities
-6.73%20.96M
-13.45%23.56M
-32.76%18.88M
-27.84%23.91M
-27.84%23.91M
-26.43%22.47M
-13.99%27.23M
-32.10%28.08M
-14.96%33.13M
-14.96%33.13M
Non current liabilities
Long term debt and capital lease obligation
-32.69%5.73M
-29.37%6.48M
-18.21%7.21M
-16.24%7.9M
-16.24%7.9M
-13.32%8.52M
-12.62%9.18M
-20.45%8.82M
-18.33%9.43M
-18.33%9.43M
-Long term capital lease obligation
-32.69%5.73M
-29.37%6.48M
-18.21%7.21M
-16.24%7.9M
-16.24%7.9M
-13.32%8.52M
-12.62%9.18M
-20.45%8.82M
-18.33%9.43M
-18.33%9.43M
Non current deferred liabilities
----
----
----
--0
--0
--0
-97.14%93K
-98.14%93K
--233K
--233K
Derivative product liabilities
--11.6M
--11.49M
--41.97M
--27.6M
--27.6M
----
----
----
--0
--0
Other non current liabilities
0.00%46K
--46K
--46K
--46K
--46K
-65.41%46K
----
----
----
----
Total non current liabilities
102.90%17.37M
94.37%18.02M
452.54%49.23M
267.77%35.54M
267.77%35.54M
-25.64%8.56M
-33.26%9.27M
-45.10%8.91M
-17.27%9.66M
-17.27%9.66M
Total liabilities
23.52%38.33M
13.94%41.58M
84.13%68.11M
38.92%59.45M
38.92%59.45M
-26.22%31.03M
-19.87%36.5M
-35.77%36.99M
-15.49%42.79M
-15.49%42.79M
Shareholders'equity
Share capital
100.00%8K
100.00%8K
75.00%7K
75.00%7K
75.00%7K
0.00%4K
0.00%4K
0.00%4K
0.00%4K
0.00%4K
-common stock
100.00%8K
100.00%8K
75.00%7K
75.00%7K
75.00%7K
0.00%4K
0.00%4K
0.00%4K
0.00%4K
0.00%4K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-16.77%-535.86M
-17.18%-516.6M
-23.59%-521.66M
-21.97%-486.8M
-21.97%-486.8M
-21.65%-458.91M
-22.94%-440.86M
-24.62%-422.07M
-31.69%-399.12M
-31.69%-399.12M
Paid-in capital
14.06%585.37M
14.38%583.33M
14.74%580.97M
15.06%578.33M
15.06%578.33M
2.83%513.23M
2.92%510M
3.04%506.32M
3.13%502.61M
3.13%502.61M
Gains losses not affecting retained earnings
16.10%577K
-0.60%494K
-4.61%476K
35.91%545K
35.91%545K
212.58%497K
894.00%497K
144.61%499K
-11.28%401K
-11.28%401K
Total stockholders'equity
-8.62%50.1M
-3.46%67.23M
-29.44%59.8M
-11.38%92.08M
-11.38%92.08M
-55.07%54.82M
-49.16%69.64M
-44.57%84.75M
-43.76%103.9M
-43.76%103.9M
Total equity
-8.62%50.1M
-3.46%67.23M
-29.44%59.8M
-11.38%92.08M
-11.38%92.08M
-55.07%54.82M
-49.16%69.64M
-44.57%84.75M
-43.76%103.9M
-43.76%103.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 6.38%74.92M4.07%94.54M8.91%112.74M7.85%135.7M7.85%135.7M-50.51%70.43M-42.99%90.84M-43.50%103.52M-34.03%125.83M-34.03%125.83M
-Cash and cash equivalents -49.83%35.33M-50.37%45.08M-69.30%24.15M66.82%135.7M66.82%135.7M-18.52%70.43M27.62%90.83M-24.76%78.67M-56.46%81.35M-56.46%81.35M
-Short-term investments --39.59M494,480.00%49.46M256.56%88.59M--0--0--0-99.99%10K-68.41%24.85M1,035.27%44.48M1,035.27%44.48M
Restricted cash 48.65%110K66.67%70K-45.59%216K-39.13%70K-39.13%70K-7.50%74K100.00%42K-74.53%397K-29.88%115K-29.88%115K
Other current assets 15.70%4.79M47.61%4.96M-7.38%5.11M-30.16%5.31M-30.16%5.31M-46.30%4.14M-59.58%3.36M-46.42%5.52M-43.79%7.6M-43.79%7.6M
Total current assets 6.94%79.82M5.65%99.57M7.89%118.06M5.65%141.08M5.65%141.08M-50.27%74.64M-43.80%94.24M-43.90%109.43M-34.67%133.55M-34.67%133.55M
Non current assets
Net PPE -24.72%7.97M-23.56%8.61M-21.10%9.21M-21.54%9.82M-21.54%9.82M-20.54%10.59M-20.81%11.26M-20.98%11.68M-16.40%12.51M-16.40%12.51M
-Gross PPE -8.48%19.51M-8.24%19.9M-4.96%20.62M-6.83%20.57M-6.83%20.57M-4.70%21.32M-4.58%21.69M-4.47%21.7M-0.67%22.08M-0.67%22.08M
-Accumulated depreciation -7.54%-11.54M-8.31%-11.29M-13.84%-11.41M-12.41%-10.76M-12.41%-10.76M-18.64%-10.73M-22.56%-10.43M-26.27%-10.02M-31.75%-9.57M-31.75%-9.57M
Other non current assets 1.93%635K1.12%631K-1.11%625K-1.42%625K-1.42%625K-4.59%623K1.30%624K2.60%632K-26.79%634K-26.79%634K
Total non current assets -23.24%8.6M-22.26%9.24M-20.07%9.84M-20.57%10.44M-20.57%10.44M-19.80%11.21M-19.89%11.89M-20.04%12.31M-57.51%13.15M-57.51%13.15M
Total assets 3.00%88.43M2.53%108.81M5.06%127.9M3.30%151.53M3.30%151.53M-47.67%85.85M-41.85%106.13M-42.16%121.74M-37.68%146.69M-37.68%146.69M
Liabilities
Current liabilities
Payables -1.68%9.75M1.16%12.58M-28.10%8.99M-25.34%9.66M-25.34%9.66M-5.94%9.91M9.07%12.43M-31.01%12.5M-37.09%12.94M-37.09%12.94M
-accounts payable -6.83%2.74M110.40%6.82M0.71%2.84M-46.87%2.52M-46.87%2.52M0.34%2.94M17.34%3.24M-24.85%2.82M57.11%4.74M57.11%4.74M
-Other payable 0.49%7.01M-37.36%5.76M-36.49%6.15M-12.91%7.14M-12.91%7.14M-8.36%6.97M6.43%9.19M-32.63%9.68M-53.27%8.2M-53.27%8.2M
Current accrued expenses 118.19%2.75M87.86%2.71M25.03%2.84M105.36%3.03M105.36%3.03M38.05%1.26M68.34%1.44M98.69%2.27M19.27%1.47M19.27%1.47M
Current debt and capital lease obligation 4.45%3.4M3.65%3.36M3.97%3.27M3.05%3.24M3.05%3.24M1.50%3.26M10.33%3.24M-4.43%3.15M8.12%3.14M8.12%3.14M
-Current capital lease obligation 4.45%3.4M3.65%3.36M3.97%3.27M3.05%3.24M3.05%3.24M1.50%3.26M10.33%3.24M-4.43%3.15M8.12%3.14M8.12%3.14M
Current deferred liabilities -83.42%655K-80.93%1.33M-89.74%721K-85.80%1.31M-85.80%1.31M-63.17%3.95M-47.06%6.95M-53.36%7.03M20.53%9.21M20.53%9.21M
Other current liabilities ---------------------91.95%7K-80.92%25K-76.04%46K-76.09%66K-76.09%66K
Current liabilities -6.73%20.96M-13.45%23.56M-32.76%18.88M-27.84%23.91M-27.84%23.91M-26.43%22.47M-13.99%27.23M-32.10%28.08M-14.96%33.13M-14.96%33.13M
Non current liabilities
Long term debt and capital lease obligation -32.69%5.73M-29.37%6.48M-18.21%7.21M-16.24%7.9M-16.24%7.9M-13.32%8.52M-12.62%9.18M-20.45%8.82M-18.33%9.43M-18.33%9.43M
-Long term capital lease obligation -32.69%5.73M-29.37%6.48M-18.21%7.21M-16.24%7.9M-16.24%7.9M-13.32%8.52M-12.62%9.18M-20.45%8.82M-18.33%9.43M-18.33%9.43M
Non current deferred liabilities --------------0--0--0-97.14%93K-98.14%93K--233K--233K
Derivative product liabilities --11.6M--11.49M--41.97M--27.6M--27.6M--------------0--0
Other non current liabilities 0.00%46K--46K--46K--46K--46K-65.41%46K----------------
Total non current liabilities 102.90%17.37M94.37%18.02M452.54%49.23M267.77%35.54M267.77%35.54M-25.64%8.56M-33.26%9.27M-45.10%8.91M-17.27%9.66M-17.27%9.66M
Total liabilities 23.52%38.33M13.94%41.58M84.13%68.11M38.92%59.45M38.92%59.45M-26.22%31.03M-19.87%36.5M-35.77%36.99M-15.49%42.79M-15.49%42.79M
Shareholders'equity
Share capital 100.00%8K100.00%8K75.00%7K75.00%7K75.00%7K0.00%4K0.00%4K0.00%4K0.00%4K0.00%4K
-common stock 100.00%8K100.00%8K75.00%7K75.00%7K75.00%7K0.00%4K0.00%4K0.00%4K0.00%4K0.00%4K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -16.77%-535.86M-17.18%-516.6M-23.59%-521.66M-21.97%-486.8M-21.97%-486.8M-21.65%-458.91M-22.94%-440.86M-24.62%-422.07M-31.69%-399.12M-31.69%-399.12M
Paid-in capital 14.06%585.37M14.38%583.33M14.74%580.97M15.06%578.33M15.06%578.33M2.83%513.23M2.92%510M3.04%506.32M3.13%502.61M3.13%502.61M
Gains losses not affecting retained earnings 16.10%577K-0.60%494K-4.61%476K35.91%545K35.91%545K212.58%497K894.00%497K144.61%499K-11.28%401K-11.28%401K
Total stockholders'equity -8.62%50.1M-3.46%67.23M-29.44%59.8M-11.38%92.08M-11.38%92.08M-55.07%54.82M-49.16%69.64M-44.57%84.75M-43.76%103.9M-43.76%103.9M
Total equity -8.62%50.1M-3.46%67.23M-29.44%59.8M-11.38%92.08M-11.38%92.08M-55.07%54.82M-49.16%69.64M-44.57%84.75M-43.76%103.9M-43.76%103.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data